Market Place
Sourcing Support
Lilly sues US agency over blocking of drug-rebate program
15 Nov 2024 //
REUTERS
Eli Lilly sues US government over proposed 340B rebate model
15 Nov 2024 //
ENDPTS
Eli Lilly`s weight-loss drug helps nearly 99% of patients remain diabetes-free
14 Nov 2024 //
REUTERS
Third Rock-Backed Trace Raises $101M to Target ALS Gene
12 Nov 2024 //
FIERCE BIOTECH
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
11 Nov 2024 //
FIERCE PHARMA
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
11 Nov 2024 //
FIERCE PHARMA
Lilly to Present at 66th ASH 2024 Annual Meeting
05 Nov 2024 //
#N/A
AstraZeneca says experimental obesity pill safe in early-stage trial
05 Nov 2024 //
REUTERS
KFSHRC & Lilly Collaborate in Alzheimer’s Early Detection
03 Nov 2024 //
GLOBENEWSWIRE
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
Lilly to Present Imlunestrant Results at Breast Cancer Symposium
01 Nov 2024 //
PR NEWSWIRE
Lilly changes lead psoriasis program from $2.4B Dice buyout
30 Oct 2024 //
FIERCE BIOTECH
Lilly cuts revenue guidance as momentum stalls for tirzepatide
30 Oct 2024 //
FIERCE PHARMA
Lilly Q3 2024 Results Show Strong Revenue Growth from New Products
30 Oct 2024 //
PR NEWSWIRE
Gradual dosing of Lilly Alzheimer`s drug cuts brain-swelling risk
30 Oct 2024 //
REUTERS
Lilly`s adjusted Kisunla regimen reduces brain swelling in trial
29 Oct 2024 //
FIERCE PHARMA
Donanemab Reduced ARIA-E In Early Symptomatic Alzheimer`s Patients
29 Oct 2024 //
PR NEWSWIRE
ViaNautis Bio Collaborates with Lilly on Genetic Medicines Platform
28 Oct 2024 //
#N/A
ViaNautis Bio Partners with Lilly for Genetic Medicines
28 Oct 2024 //
GLOBENEWSWIRE
Lilly’s Mirikizumab Shows Long-Term Efficacy in Colitis, Crohn`s
28 Oct 2024 //
PR NEWSWIRE
Lilly declares fourth-quarter 2024 dividend
28 Oct 2024 //
PR NEWSWIRE
Eli Lilly gets nod to launch weight-loss drug in Hong Kong
28 Oct 2024 //
REUTERS
J&J`s Tremya, Lilly`s Ebglyss score in new patient groups
25 Oct 2024 //
FIERCE PHARMA
Lilly’s Donanemab Offers Hope to Alzheimer’s Patients in Australia
25 Oct 2024 //
EXPRESSPHARMA
England`s NICE not sold on Lilly`s Kisunla despite UK approval
24 Oct 2024 //
FIERCE PHARMA
Weight-loss drugs didn`t curb health costs within two years
24 Oct 2024 //
REUTERS
Lilly’s Kisunla™ Receives Authorization For Alzheimer’s Treatment
23 Oct 2024 //
PR NEWSWIRE
UK`s NHS to block Eli Lilly`s Alzheimer`s drug on Wednesday
23 Oct 2024 //
REUTERS
Senators demand answers on telehealth platforms from Pfizer and Eli Lilly
23 Oct 2024 //
STAT NEWS
Lilly sues online vendors, medical spa over copycat weight-loss drugs
22 Oct 2024 //
REUTERS
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
21 Oct 2024 //
GLOBENEWSWIRE
Eli Lilly joins OAC campaign against obesity stigma
18 Oct 2024 //
FIERCE PHARMA
Lilly shows restroom rarity affects ulcerative colitis patients
17 Oct 2024 //
FIERCE PHARMA
Survey: 8 In 10 Americans With Ulcerative Colitis Struggle For Restrooms
16 Oct 2024 //
PR NEWSWIRE
Lilly Sets Date For Q3 2024 Financial Results Announcement
16 Oct 2024 //
PR NEWSWIRE
Britain to study use of Lilly`s weight loss drug to get back to work
15 Oct 2024 //
REUTERS
Lilly reports Ph 3 study of mirikizumab compared to ustekinumab for Crohn
15 Oct 2024 //
PR NEWSWIRE
FDA reviews decision to put Lilly`s tirzepatide on shortage list
14 Oct 2024 //
FIERCE PHARMA
FDA to reconsider decision barring compounded versions of Lilly drug
14 Oct 2024 //
REUTERS
Eli Lilly inks another obesity pact, down on small Swiss partner
12 Oct 2024 //
PR NEWSWIRE
Lilly goes all-in on AI with new exec position
11 Oct 2024 //
FIERCE BIOTECH
In China, Lilly plans $200M expansion to make tirzepatide meds
11 Oct 2024 //
FIERCE PHARMA
Foghorn Doses First Patient With FHD-909 In SMARCA4 Solid Tumors
10 Oct 2024 //
GLOBENEWSWIRE
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
10 Oct 2024 //
BUSINESSWIRE
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
09 Oct 2024 //
BUSINESSWIRE
Ebglyss FDA Approval Intensifies Atopic Dermatitis Competition
08 Oct 2024 //
FINANCIALXPRESS
Minus one of its GLP-1 cash cows, compounding group sues FDA
08 Oct 2024 //
FIERCE PHARMA
Qinotto and Lilly Enter Research Collaboration and License Agreement
08 Oct 2024 //
GLOBENEWSWIRE
Compounding Group Sues FDA Over Lilly`s Weight Loss Drug
07 Oct 2024 //
REUTERS
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
07 Oct 2024 //
FIERCE PHARMA
NHS England proposes phased rollout for Lilly`s obesity med
04 Oct 2024 //
FIERCE PHARMA
Lilly`s weight-loss drug removed from FDA`s shortage list
04 Oct 2024 //
BUSINESSWIRE
England`s NHS to offer Lilly`s weight-loss drug to some patients
03 Oct 2024 //
REUTERS
US FDA says Lilly`s weight-loss drug no longer in shortage
03 Oct 2024 //
REUTERS
Lilly to invest $4.5B on new facility to scale-up drug production
02 Oct 2024 //
REUTERS
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
01 Oct 2024 //
BIOPHARMADIVE
Roche targets more than $3 billion in annual obesity sales
01 Oct 2024 //
REUTERS
Lilly`s Ebglyss Shows 3-Year Atopic Dermatitis Control
25 Sep 2024 //
PR NEWSWIRE
Eli Lilly`s Alzheimer`s drug approved in Japan
25 Sep 2024 //
PRESS RELEASE
